doi:10.3969/j.issn.1673-8640.2018.03.018

Abstract

CLC Number:

R446.1

Figures/Tables 2

References 10

1	KATAYAMA T,NAKASHIMA H,TAKAGI C,et al. Serum amyloid a protein as a predictor of cardiac rupture in acute myocardial infarctin patients following primary coronary angioplasty[J]. Circ J,2006,70(5):530-535.
2	朱华,王娟,林燕,等. 血清淀粉样蛋白A的研究进展[J]. 心血管病学进展,2007,28(1):113-115.
3	何俊英,刘艳,周志斌,等. 手足口病患儿三种急性时相反应蛋白的变化[J]. 检验医学,2015,30(6):657-658.
4	沈伟虹,岳朝艳,孙振东,等. 血清淀粉样蛋白A与C反应蛋白联合检测在新生儿细菌感染诊断中的应用[J]. 检验医学,2016,31(3):173-175.
5	杨剑敏,叶辉,张泓. CRP和SAA在儿童上呼吸道感染中的鉴别诊断价值[J]. 检验医学,2016,31(8):679-680.
6	田月如,李巍,叶志成,等. 血清淀粉样蛋白A和C反应蛋白检测在儿童感染性疾病诊断中的应用[J]. 检验医学,2017,32(5):382-385.
7	FU Y,CHEN J,CAI B,et al. The use of PCT,CRP,IL-6 and SAA in critically ill patients for an early distinction between candidemia and Gram positive/negative bacteremia[J]. J Infect,2012,64(4):438-440.
8	DOS ANJOS B L,GROTTO H Z. Evaluation of C-reactive protein and serum amyloid A in the detection of inflammatory and infectious diseases in children[J]. Clin Chem Lab Med,2010,48(4):493-499.
9	张衍胜,王洋,荣杰. 联合应用SAA、PCT、CRP对小儿感染性疾病的早期鉴别诊断价值[J].中国保健营养(中旬刊),2013,12(12):52.
10	URIELI-SHOVAL S,LINKE R P,MATZNER Y. Expression and function of serum amyloid A,a major acute-phase protein,in normal and disease states[J]. Curr Opin Hematol,2000,7(1):64-69.

病因	例数	百分比（%）
感染性腹泻	923	85.0
轮状病毒	567	52.2
腺病毒	40	3.7
诺如病毒	31	2.9
其他病毒	21	1.9
细菌	116	10.7
真菌	35	3.2
其他	113	10.4
非感染性腹泻	163	15.0
糖原性	57	5.2
药物性	37	3.4
症状性	19	1.7
乳糜性	10	0.9
过敏性	5	0.5
其他	35	3.2

病因	例数	百分比（%）
感染性腹泻	923	85.0
轮状病毒	567	52.2
腺病毒	40	3.7
诺如病毒	31	2.9
其他病毒	21	1.9
细菌	116	10.7
真菌	35	3.2
其他	113	10.4
非感染性腹泻	163	15.0
糖原性	57	5.2
药物性	37	3.4
症状性	19	1.7
乳糜性	10	0.9
过敏性	5	0.5
其他	35	3.2

组别	例数	SAA	hs-CRP
细菌性腹泻组	151	298.56±62.12	33.35±12.61
病毒性腹泻组	659	99.35±26.82^*	6.17±1.22^*
非感染性腹泻组	163	8.21±2.12^*#	4.15±0.62^*#

组别	例数	SAA	hs-CRP
细菌性腹泻组	151	298.56±62.12	33.35±12.61
病毒性腹泻组	659	99.35±26.82^*	6.17±1.22^*
非感染性腹泻组	163	8.21±2.12^*#	4.15±0.62^*#

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 10

Related Articles 15

Recommended Articles

Metrics